KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Debt Ratio (2020 - 2025)

Recursion Pharmaceuticals (RXRX) has disclosed Debt Ratio for 6 consecutive years, with 0.01 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio fell 33.21% year-over-year to 0.01, compared with a TTM value of 0.01 through Dec 2025, down 33.21%, and an annual FY2025 reading of 0.01, down 33.21% over the prior year.
  • Debt Ratio was 0.01 for Q4 2025 at Recursion Pharmaceuticals, down from 0.01 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.04 in Q2 2024 and bottomed at 0.0 in Q4 2022.
  • Average Debt Ratio over 5 years is 0.01, with a median of 0.0 recorded in 2024.
  • The sharpest move saw Debt Ratio crashed 97.82% in 2022, then surged 2208.58% in 2024.
  • Year by year, Debt Ratio stood at 0.0 in 2021, then fell by 26.3% to 0.0 in 2022, then surged by 128.57% to 0.0 in 2023, then skyrocketed by 984.57% to 0.02 in 2024, then plummeted by 33.21% to 0.01 in 2025.
  • Business Quant data shows Debt Ratio for RXRX at 0.01 in Q4 2025, 0.01 in Q3 2025, and 0.02 in Q2 2025.